Early Access — free while we kick the tires
EdgarHawk

Farshchi Jamil

EVP, Chief Technology Officer

Officer
4 filings analyzed · 1 company · Latest 2026-02-12

Companies

Company Buys Sells Direction
EQUIFAX INC EFX 0 15 Net selling

Activity

February 2026
2026-02-12 EQUIFAX INC EFX
medium
Sell
7,380 shares
$1,449,816
Significance 5/10

CTO Jamil Farshchi sells 7,380 shares (15.6% of holdings) for $1.4M at $196.45 avg; stock down 32.9% from 52-week high

Jamil Farshchi, EVP and Chief Technology Officer, executed 2 separate sales totaling 7,380 shares for $1,449,815.82 on 2026-02-10 and 2026-02-11 at prices of $195.81 and $199.87 respectively. The sales reduce his holdings by 15.6%, from 47,249 shares to 39,869 shares. The transaction timing is notable: Equifax stock is down 32.9% from its 52-week high of $280.54, currently trading at $188.18, which is below the sale prices of $196.45 (blended average). Farshchi's prior 3 sales at Equifax show a 66.67% well-timed rate at the 90-day mark, with his most recent EFX sale (2025-10-27) followed by a 12.2% decline over 90 days. However, his track record is not uniform: the 2025-02-12 sale saw a +10.3% 90-day return, indicating not all prior sales preceded declines. The current market environment—with EFX shares down 13.5% over 30 days and 9.2% over 90 days—suggests the timing of these recent sales may align with the insider's demonstrated 90-day pattern at this ticker.

October 2025
2025-10-28 EQUIFAX INC EFX
medium
Sell
4,925 shares
$1,176,780
Significance 4/10

EFX CTO Jamil Farshchi sold 4,925 shares at $238.94; stock down -20.1% from 52-week high and -11.8% in 30 days.

Jamil Farshchi, Chief Technology Officer of Equifax, sold 4,925 shares (11.1% reduction in holdings) at $238.94 on October 27, 2025, reducing his stake from 44.3K to 39.4K shares. This sale occurred as the stock trades at $224.16, down -20.1% from its 52-week high of $280.54 and down -11.8% over the prior 30 days, representing a meaningful price decline from the transaction date. Across Farshchi's prior two sales at EFX (February 2025 and November 2024), one of two was well-timed at the 90-day mark, though his broader cross-ticker track record shows 50% well-timed sales with mixed 30- and 90-day return patterns. The current valuation context shows a P/E of 41.67 against $1.5B quarterly revenue and $160.2M net income, suggesting investors should monitor whether further declines or insider activity patterns emerge.

February 2025
2025-02-13 EQUIFAX INC EFX
medium
Sell
18,911 shares
$4,693,332
Significance 4/10

Farshchi (EVP, CISO & CTO) sold 18,911 shares of EFX at $248.18 for $4.7M on 2025-02-12, reducing holdings 32.5%.

Farshchi sold approximately one-third of his EFX holdings at $248.18, with the stock currently trading at $250.87 near the lower end of its 52-week range ($216.20–$307.13). His cross-ticker track record shows 1 prior sell with an average 30-day return of -0.6%, and his same-ticker history at EFX includes one prior sale on 2024-11-26 (30-day return -0.6%). The transaction itself is material in absolute terms ($4.7M), but the insider retains 39,252 shares post-transaction, indicating a significant residual stake. Equifax's fundamentals show revenue of $1,441,800,000.00 and net income of $141,300,000.00 in the latest quarter, though the P/E of 55.26 reflects a premium valuation relative to earnings.

November 2024
2024-11-27 EQUIFAX INC EFX
medium
Sell
14,716 shares
$3,831,899
Significance 5/10

CISO Farshchi sells 14,716 EFX shares at $260.39; reduces stake 29.8% to 34,632 shares

Jamil Farshchi, EVP, CISO & Acting CTO, executed a sale of 14,716 shares at $260.39 on 2024-11-26 for $3,831,899.24, reducing his holdings by 29.8% from 49,348 to 34,632 shares. The sale occurs at a price 0.3% below the current market level of $261.19, and -15.0% from the 52-week high of $307.13, suggesting a non-opportunistic execution. The stock has declined 14.0% over the 90-day period and 3.3% in the past 30 days. With a forward P/E of 57.53 and revenue growth of +2.8% against $1,441,800,000.00 in quarterly revenue, the company's valuation premium is not supported by robust organic growth momentum.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access